The BLRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BLRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The BLRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View BLRX Detailed Price Forecast - CNN Money | View BLRX Detailed Summary - Google Finance | ||
View BLRX Detailed Summary - Yahoo! Finance | View BLRX Stock Research & Analysis - Zacks.com |
View BLRX Trends & Analysis - Trade-Ideas | View BLRX Major Holders - Barrons | ||
View BLRX Call Transcripts - NASDAQ | View BLRX Breaking News & Analysis - Seeking Alpha | ||
View BLRX Annual Report - CompanySpotlight.com | View BLRX OTC Short Report - OTCShortReport.com | ||
View BLRX Fundamentals - TradeKing | View BLRX SEC Filings - Bar Chart | ||
View Historical Prices for BLRX - The WSJ | View Performance/Total Return for BLRX - Morningstar | ||
View the Analyst Estimates for BLRX - MarketWatch | View the Earnings History for BLRX - CNBC | ||
View the BLRX Earnings - StockMarketWatch | View BLRX Buy or Sell Recommendations - MacroAxis | ||
View the BLRX Bullish Patterns - American Bulls | View BLRX Short Pain Metrics - ShortPainBot.com |
View BLRX Stock Mentions - StockTwits | View BLRX Stock Mentions - PennyStockTweets | ||
View BLRX Stock Mentions - Twitter | View BLRX Investment Forum News - Investor Hub | ||
View BLRX Stock Mentions - Yahoo! Message Board | View BLRX Stock Mentions - Seeking Alpha |
View Insider Transactions for BLRX - SECform4.com | View Insider Transactions for BLRX - Insider Cow | ||
View BLRX Major Holdings Summary - CNBC | View Insider Disclosure for BLRX - OTC Markets | ||
View Insider Transactions for BLRX - Yahoo! Finance | View Institutional Holdings for BLRX - NASDAQ |
View BLRX Stock Insight & Charts - FinViz.com | View BLRX Investment Charts - StockCharts.com | ||
View BLRX Stock Overview & Charts - BarChart | View BLRX User Generated Charts - Trading View |
BioLineRx Ltd. (NASDAQ:BLRX) Q4 2023 Earnings Call Transcript
Posted on Wednesday March 27, 2024
BioLineRx Ltd. (NASDAQ:BLRX) Q4 2023 Earnings Call Transcript March 26, 2024 BioLineRx Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Fourth Quarter and Full Year 2023 Financial […]
BLRX: First Aphexda Sales Recognized
Posted on Wednesday March 27, 2024
By John Vandermosten, CFA NASDAQ:BLRX READ THE FULL BLRX RESEARCH REPORT Since the 3Q:23 report in November, BioLineRx Ltd. (NASDAQ:BLRX) has been focused on Aphexda commercialization following drug approval in September 2023. Since then, two other trials evaluating motixafortide have dosed first patients. One was the gene therapy trial in collaboration with the Washington University School of
BioLineRx Reports 2023 Financial Results and Recent Corporate and Portfolio Updates
Posted on Tuesday March 26, 2024
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its financial results for the year ended December 31, 2023, and provided recent corporate and portfolio updates.
BioLineRx to Report 2023 Annual Financial Results on March 26, 2024
Posted on Wednesday March 20, 2024
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced it will release its audited financial results for the year ended December 31, 2023 on Tuesday, March 26, 2024, before the U.S. markets open.